Companies

Companies

featured image of Breaking News: Groundbreaking Medicines Production Center Revolutionizes Drug Supply!

Breaking News: Groundbreaking Medicines Production Center Revolutionizes Drug Supply!

BIOT

🔴🏭 Applied Pharmaceutical Innovation and University of Alberta break ground on Critical Medicines Production Center, boosting drug supply chain. 💊💰

featured image of Shocking Impact of Biopharmaceutical Act on US-China Partnership

Shocking Impact of Biopharmaceutical Act on US-China Partnership

BIOT

📢 The BIOSECURE Act could impact over 120 US biopharmaceutical drugs partnered with Chinese companies 'of concern'. 💊🇺🇸🔒⚠️🔄

featured image of Danone Michelin and DMC Biotechnologies Join Forces for Revolutionary Fermentation Center

Danone Michelin and DMC Biotechnologies Join Forces for Revolutionary Fermentation Center

BIOT

🌍🧬🏭 Danone, Michelin, DMC Biotechnologies, and Crédit Agricole have joined forces to create a groundbreaking fermentation center in France. 🇫🇷🥛🧪

featured image of Fujifilm Diosynth Invests $12B in Massive NC Expansion

Fujifilm Diosynth Invests $12B in Massive NC Expansion

BIOT

📢 Fujifilm Diosynth Biotechnologies invests $1.2B to expand biomanufacturing facility in NC, creating 680 new jobs. 🏭💼🌍📈

featured image of Solugen Secures $2136M for Green Production Facility

Solugen Secures $2136M for Green Production Facility

BIOT

📢 Solugen receives $213.6M commitment from U.S. Department of Energy to build a biobased production facility in Minnesota. 🏭🌱👷✅

featured image of Evotec SE Makes €20m Cash Milestone

Evotec SE Makes €20m Cash Milestone

BIOT

💰 Evotec SE celebrates €20m milestone payment from partnership with Bristol Myers Squibb! 🎉 Exciting advancements in neurologic disease research!

featured image of Tacalyx Raises €14m to Develop Cancer Therapies

Tacalyx Raises €14m to Develop Cancer Therapies

BIOT

1. 🌱 Tacalyx raises €14m in seed financing to develop anti-TACA cancer therapies. Exciting advancements in cancer treatment! 💪🔬🎗️ 2. Tacalyx secures €14m in seed capital financing, led by Thuja Capital. Promising developments in anti-TACA cancer therapies. 🌟💰🔬

featured image of GSK's $50m Acquisition Revolutionizes Oligonucleotide Drug Development

GSK’s $50m Acquisition Revolutionizes Oligonucleotide Drug Development

BIOT

📢 GSK acquires Elsie Biotechnologies in a $50m deal to enhance its drug platform and develop treatments for difficult-to-treat diseases. 🧬👥🚀

featured image of Vetter's Explosive Expansion: More Jobs Bigger Capacity!

Vetter’s Explosive Expansion: More Jobs Bigger Capacity!

BIOT

📢 Vetter, the CDMO, is expanding in the U.S. and Germany to meet growing demand in the injectable industry. 💼

featured image of Entos Pharmaceuticals Expands Manufacturing Powerhouse

Entos Pharmaceuticals Expands Manufacturing Powerhouse

BIOT

📢 Entos Pharmaceuticals opens GMP facility in Carlsbad, CA to support studies and trials, advancing pipeline of 20 programs. 🔬💰🌎